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INTRODUCTION
•  Sudden cardiac arrest (SCA) is a common cause of death in the 
United States and worldwide.
•  In 2016, approximately 350,000 adult patients experienced SCA in 
the US with less than 15% chance of survival to hospital discharge. 
•  Based on superiority of Implantable Cardioverter Defibrillator (ICD) 
treatment, societal guidelines assigned a class IA indication for  
ICD implantation in survivors of SCA in whom no reversible etiology  
is identified
•  However, there are limited available data on contemporary ICD 
utilization in this subgroup of patients
OBJECTIVE
•  We evaluated a nationally representative sample of U.S. population 
to assess disparities in ICD usage across various subgroups in this 
patient population. 
METHODS 
•  We identified patients ≥18 years of age with a primary discharge 
diagnosis of SCA (ICD 9: 427.5) from January 2003 to December 
2014 using National Inpatient Sample (NIS) 
•  Patients who died during hospitalization and had previous ICD 
implant (ICD-9CM codes 37.97 and 37.98) were then excluded
•  Furthermore, we excluded patients with any reversible causes of 
SCA from the final study cohort.
•  Transmural myocardial infarction, tension pneumothorax, cardiac 
tamponade, pulmonary embolism, hypokalemia, hyperkalemia, hypo-
thermia, and hypovolemia were defined as reversible causes of SCA.
•  Baseline demographics and clinical features were studied.
•  The primary outcome of interest was rates and trends of new ICD 
implants during the incident hospitalization. 
RESULTS
•  We identified a total of 623,257 patients with primary 
diagnosis of SCA and alive at hospital discharge. 
•  Of these, 73.2% had out of hospital CA (OHCA), and 
33.6% had documented Ventricular Tachycardia/ 
Ventricular Fibrillation.
•  The mean age of these patients was 64+/-15 years, 
56.6% were males, and 70.6% were Caucasians. 
•  Out of this, only 43,323 (7.0%) patients were implanted 
with an ICD during incident hospitalization (Figure 1). 
•  There was a significant trend towards reduced ICD 
implantation during our study period (8.1%% in 2003 vs 
6.5% in 2014, P trend < 0.0001) (Figure 1).
•  OHCA, age< 65 years, male sex, Caucasians, and use of 
EP study were independently associated with higher ICD 
utilization.
CONCLUSION
•  The rates of ICD implantation in survivors of SCA due to irreversible cause are  
low and have also declined between 2003 and 2014
•  Patients who did not receive an ICD were older and had a distinctive risk profile 
compared with those who received an ICD prior to discharge
•  There is a need to identify barriers behind low ICD utilization in this vulnerable 
group and might have important health care policy implications.
LIMITATIONS
•  Retrospective design of the study and possibility of varying coding practices of  
the hospital.
•  NIS allows a detailed assessment of in-hospital outcomes. However, follow-up 
beyond hospital discharge is not available. 
•  We could not analyze the impact of certain important factors (medical staff 
awareness of the guidelines, patient’s preference, etc.) on the utilization rates of 
ICD in this cohort
Table 1: Baseline demographic and procedural characteristics of 
patients survived to hospital discharge after SCA
Total SCA IHCA OHCA
SCA alive  
on hospital 
discharge
623,257 167,101 (26.8%) 456,156 (73.2%)
VT/VF 209,479 (33.6%) 52,514 (31.4%) 156,965 (34.4%)
Age; Mean (SD) 64 (15) 65 (15) 64(15)
Male (%) 352,766 (56.6%) 91,378 (54.7%) 261,388 (57.3%)
Caucasian (%) 369,459 (70.6%) 97,684 (66.6%) 271,775 (72.2%)
EP study (%) 10,533 (1.7%) 1,675 (1.0%) 8,858 (1.9%)
ICD implant  
on hospital 
discharge (%)
43,323 (7.0%) 6,955 (4.2%) 36,368 (8.0%)
ICD implant for 
VT/VF (%) 37011 (17.7%) 5,915 (11.3%) 31,096 (19.8%)
Figure 1: Trends in implantable cardioverter 
defibrillator implantation over study years, 
2003–2014.
Figure 2: Trends in implantable cardioverter 
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